While still a ways away from mass production, a vaccine for COVID-19 may soon be approved. In a recent interview, 2nd District Representative Brett Guthrie says 3 different versions are nearing trial completion.
One trial that is currently underway that Guthrie highlighted is Pfizer, which he says is conducting a 30,000 patient study. Guthrie says that, while a mass rollout is still expected for the first of the year, those who would receive it first would be frontline healthcare workers, the elderly, as well as those with comorbidities.